One-step multiplex analysis of breast cancer exosomes using an electrochemical strategy assisted by gold nanoparticles
Analytica Chimica Acta · 2023
DOI: 10.1016/j.aca.2023.341130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2023. Verfasst von Mingwan Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Key Laboratory for Bio-Nanotechnology and M…. Hauptthemen laut MEDLINE: Breast Neoplasms, Exosomes, Metal Nanoparticles, Aptamers, Nucleotide. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Scientific Research Foundation of Hunan Provincial Education Department, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Exosomes, as a non-invasive biomarker, perform an important role in breast cancer screening and prognosis monitoring. However, establishing a simple, sensitive, and reliable exosome analysis technique remains challenging. Herein, a one-step multiplex analysis electrochemical aptasensor based on a multi-probe recognition strategy was constructed to analyze breast cancer exosomes. HER2-positive breast cancer cell (SK-BR-3) exosomes were selected as the model targets and three aptamers including CD63, HER2 and EpCAM aptamers were used as the capture units. Methylene blue (MB) functionalized HER2 aptamer and ferrocene (Fc) functionalized EpCAM aptamer, which were modified on gold nanoparticles (Au NPs), i.e. MB-HER2-Au NPs and Fc-EpCAM-Au NPs, were used as signal units. When the mixture of target exosomes, MB-HER2-Au NPs and Fc-EpCAM-Au NPs were added on the CD63 aptamer modified gold electrode, two Au NPs modified by MB and Fc could be specifically captured on the electrode by the recognition of three aptamers with target exosomes. Then one-step multiplex analysis of exosomes was achieved by detecting two independent electrochemical signals. This strategy can not only distinguish breast cancer exosomes from other exosomes (including normal exosomes and other tumor exosomes) but also HER2-positive breast cancer exosomes and HER2-negative breast cancer exosomes. Besides, it had high sensitivity and can detect SK-BR-3 exosomes with a concentration as low as 3.4 × 103 particles mL-1. Crucially, this method can be applicable to the examination of exosomes in complicated samples, which is anticipated to afford assistance for the screening and prognosis of breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Key Laboratory for Bio-Nanotechnology and Molecular Engineering of Hunan Province, Hunan University, Changsha, 41…
Förderung
- Scientific Research Foundation of Hunan Provincial Education Department
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- National Key Research and Development Program of China Stem Cell and Translational Research
Zitieren
APA
Zhang, M., Xia, L., Mei, W., Zou, Q., Liu, H., Wang, H., Zou, L., Wang, Q., Yang, X., & Wang, K. (2023). One-step multiplex analysis of breast cancer exosomes using an electrochemical strategy assisted by gold nanoparticles. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2023.341130
Vancouver
Zhang M, Xia L, Mei W, Zou Q, Liu H, Wang H, et al. One-step multiplex analysis of breast cancer exosomes using an electrochemical strategy assisted by gold nanoparticles. Analytica Chimica Acta. 2023. doi:10.1016/j.aca.2023.341130
BibTeX
@article{Zhang2023,
author = {Zhang, Mingwan and Xia, Ling and Mei, Wenjing and Zou, Qingqing and Liu, Hui and Wang, Hongqiang and Zou, Liyuan and Wang, Qing and Yang, Xiaohai and Wang, Kemin},
title = {One-step multiplex analysis of breast cancer exosomes using an electrochemical strategy assisted by gold nanoparticles},
journal = {Analytica Chimica Acta},
year = {2023},
doi = {10.1016/j.aca.2023.341130}
}
EUVIMED